Inari Medical Past Earnings Performance

Past criteria checks 0/6

Inari Medical's earnings have been declining at an average annual rate of -63.8%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 28.9% per year.

Key information

-63.8%

Earnings growth rate

-61.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate28.9%
Return on equity-13.5%
Net Margin-10.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Inari Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:IM7 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24547-5739796
31 Mar 24521-2436892
31 Dec 23494-235188
30 Sep 23469-334085
30 Jun 23439-1632783
31 Mar 23413-2831580
31 Dec 22383-2929374
30 Sep 22359-2225873
30 Jun 22336-1523966
31 Mar 22306-120859
31 Dec 212771019051
30 Sep 212421616739
30 Jun 212082513432
31 Mar 211701711024
31 Dec 20140149018
30 Sep 2011177215
30 Jun 208615911
31 Mar 20714489
31 Dec 1951-1377
31 Dec 187-10114

Quality Earnings: IM7 is currently unprofitable.

Growing Profit Margin: IM7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IM7 is unprofitable, and losses have increased over the past 5 years at a rate of 63.8% per year.

Accelerating Growth: Unable to compare IM7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IM7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: IM7 has a negative Return on Equity (-13.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies